falsehttp://fasb.org/us-gaap/2022#AccountingStandardsUpdate201812MemberQ1http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201812Memberhttp://fasb.org/us-gaap/2022#AccountingStandardsUpdate201812Memberhttp://fasb.org/us-gaap/2022#AccountingStandardsUpdate201812Memberhttp://fasb.org/us-gaap/2022#RealizedInvestmentGainsLosseshttp://fasb.org/us-gaap/2022#AccountingStandardsUpdate201812Member--12-31http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201812Memberhttp://fasb.org/us-gaap/2022#AccountingStandardsUpdate201812Memberhttp://fasb.org/us-gaap/2022#AccountingStandardsUpdate201812Memberhttp://www.primerica.com/20230331#SeniorHealthSegmentRevenuesMember0001475922http://fasb.org/us-gaap/2022#RealizedInvestmentGainsLosses0001475922us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2022-12-310001475922us-gaap:FairValueInputsLevel1Memberpri:FixedMaturitySecuritiesAndShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922pri:OtherAssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2022-12-310001475922us-gaap:AllowanceForCreditLossMember2022-12-310001475922pri:TermLifeInsuranceSegmentRevenuesMember2022-12-310001475922us-gaap:SeniorNotesMember2023-01-012023-03-310001475922us-gaap:CommonStockMember2022-01-012022-12-310001475922us-gaap:RestrictedStockUnitsRSUMember2023-02-272023-02-270001475922pri:SegmentRevenuesFromContractsWithCustomersMemberpri:SeniorHealthSegmentRevenuesMemberpri:CommissionsAndFeesMember2023-01-012023-03-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberpri:SeniorHealthSegmentRevenuesMember2022-01-012022-03-310001475922pri:DepositAssetUnderlying10InsuranceAgreementMember2022-03-310001475922us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922pri:ShortTermInvestmentMember2023-03-310001475922country:US2022-01-012022-03-310001475922pri:LLCNoteMember2023-01-012023-03-310001475922pri:ShortTermInvestmentMember2022-12-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922pri:SwissReLifeHealthAmericaIncMembersrt:AMBestAPlusRatingMember2022-12-310001475922us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922us-gaap:CorporateAndOtherMemberpri:RevenuesFromSourcesOtherThanContractsWithCustomersMember2023-01-012023-03-310001475922us-gaap:EquitySecuritiesMember2023-03-310001475922pri:ExternalCreditRatingNotRatedMemberpri:MunichReOfMaltaMember2023-03-310001475922us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMemberus-gaap:AccumulatedOtherComprehensiveIncomeMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-01-012021-12-310001475922us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310001475922pri:OtherMember2022-12-310001475922country:US2023-03-310001475922us-gaap:CommonStockMember2022-12-310001475922us-gaap:FairValueInputsLevel2Memberpri:OtherAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922pri:InvestmentAndSavingsProductsSegmentRevenuesMember2023-03-310001475922pri:TermLifeInsuranceSegmentRevenuesMember2022-01-012022-03-310001475922pri:EtelequoteBermudaMember2021-07-010001475922us-gaap:FixedMaturitiesMember2022-12-310001475922us-gaap:AllowanceForCreditLossMember2023-03-310001475922us-gaap:FairValueInputsLevel3Memberpri:FixedMaturitySecuritiesAndShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922us-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2023-01-012023-03-310001475922us-gaap:FairValueInputsLevel1Memberpri:FixedMaturitySecuritiesAndShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922pri:SegregatedFundsCanadaMember2023-01-012023-03-310001475922us-gaap:ShortTermInvestmentsMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2023-03-310001475922us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922us-gaap:EquitySecuritiesMember2023-01-012023-03-310001475922pri:SeniorHealthSegmentRevenuesMember2022-01-012022-03-310001475922us-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001475922us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2022-12-310001475922country:US2022-12-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberus-gaap:CorporateAndOtherMemberus-gaap:OtherIncomeMember2022-01-012022-03-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberpri:AssetBasedRevenuesMemberpri:CommissionsAndFeesMemberpri:InvestmentAndSavingsProductsSegmentRevenuesMember2023-01-012023-03-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberpri:SeniorHealthSegmentRevenuesMemberpri:CommissionsAndFeesMember2022-01-012022-03-310001475922us-gaap:CommonStockMember2020-12-3100014759222020-12-310001475922us-gaap:RetainedEarningsMembersrt:ScenarioPreviouslyReportedMember2021-12-3100014759222021-01-012021-01-010001475922us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2022-12-310001475922us-gaap:AccumulatedOtherComprehensiveIncomeMembersrt:ScenarioPreviouslyReportedMember2021-12-310001475922pri:OtherAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922pri:DepositAssetUnderlying10InsuranceAgreementMember2023-01-012023-03-310001475922us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001475922us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001475922pri:EtelequoteBermudaMember2022-07-010001475922pri:SegmentRevenuesFromContractsWithCustomersMemberus-gaap:OtherIncomeMemberpri:TermLifeInsuranceSegmentRevenuesMember2023-01-012023-03-310001475922pri:DepositAssetUnderlying10InsuranceAgreementMember2023-03-310001475922pri:OtherMember2022-12-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberus-gaap:OtherIncomeMemberpri:InvestmentAndSavingsProductsSegmentRevenuesMember2022-01-012022-03-310001475922pri:InvestmentAndSavingsProductsSegmentRevenuesMember2023-01-012023-03-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberpri:SeniorHealthSegmentRevenuesMember2023-01-012023-03-310001475922srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMemberus-gaap:AccumulatedOtherComprehensiveIncomeMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2020-12-310001475922pri:OtherMember2023-03-310001475922pri:SwissReLifeHealthAmericaIncMembersrt:AMBestAPlusRatingMember2023-03-310001475922us-gaap:RestrictedStockUnitsRSUMember2023-03-310001475922us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922pri:DueToFromFundsNettingArrangementMember2022-12-310001475922us-gaap:PerformanceSharesMember2023-02-272023-02-270001475922pri:OtherAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922pri:AccountBasedRevenuesMember2023-01-012023-03-310001475922us-gaap:RevolvingCreditFacilityMembersrt:MinimumMemberus-gaap:BaseRateMember2023-01-012023-03-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922srt:MinimumMemberus-gaap:PerformanceSharesMember2023-02-272023-02-270001475922us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922srt:ScenarioPreviouslyReportedMember2022-12-310001475922country:CA2023-01-012023-03-310001475922us-gaap:ResidentialMortgageBackedSecuritiesMember2023-03-310001475922us-gaap:CashAndCashEquivalentsMember2023-03-310001475922us-gaap:RetainedEarningsMembersrt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-01-012021-12-310001475922us-gaap:CorporateAndOtherMember2022-12-310001475922us-gaap:FairValueInputsLevel2Memberpri:FixedMaturitySecuritiesAndShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922us-gaap:SeniorNotesMember2023-03-310001475922us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FixedMaturitiesMember2022-12-310001475922us-gaap:CommonStockMember2022-01-012022-03-3100014759222023-01-012023-03-3100014759222022-01-012022-12-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberpri:SeniorHealthSegmentRevenuesMemberus-gaap:OtherIncomeMember2023-01-012023-03-310001475922pri:EtelequoteBermudaMember2021-07-012021-07-010001475922us-gaap:CorporateAndOtherMember2023-03-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberpri:TermLifeInsuranceSegmentRevenuesMember2022-01-012022-03-310001475922us-gaap:FairValueInputsLevel3Member2022-12-310001475922srt:MaximumMemberus-gaap:PerformanceSharesMember2023-02-272023-02-270001475922us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310001475922us-gaap:CommercialMortgageBackedSecuritiesMember2023-03-310001475922us-gaap:USStatesAndPoliticalSubdivisionsMember2023-03-310001475922pri:InvestmentAndSavingsProductsSegmentRevenuesMember2022-01-012022-03-310001475922us-gaap:RevolvingCreditFacilityMembersrt:MinimumMember2023-01-012023-03-310001475922pri:TemporaryStockholdersEquityMember2022-01-012022-03-310001475922us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922us-gaap:FixedMaturitiesMember2023-03-310001475922pri:AllOtherReinsurersMember2022-12-310001475922us-gaap:OtherInsuranceProductLineMember2022-12-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922pri:KoreanReinsuranceCompanyMembersrt:AMBestARatingMember2022-12-310001475922pri:HannoverLifeReassuranceCompanyMembersrt:AMBestAPlusRatingMember2022-12-310001475922pri:AccountBasedRevenuesMember2022-01-012022-03-310001475922srt:AMBestAPlusRatingMemberpri:SwissReLifeHealthAmericaIncNovatedFromPecanReIncMember2022-12-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberus-gaap:CorporateAndOtherMemberpri:CommissionsAndFeesMember2022-01-012022-03-310001475922us-gaap:FairValueInputsLevel3Member2023-03-310001475922pri:TemporaryStockholdersEquityMember2021-12-310001475922us-gaap:RetainedEarningsMember2022-03-310001475922us-gaap:ShortTermInvestmentsMemberus-gaap:USTreasuryAndGovernmentMember2023-03-3100014759222022-01-012022-03-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001475922pri:TermLifeAndOtherMember2022-12-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberpri:InvestmentAndSavingsProductsSegmentRevenuesMember2022-01-012022-03-310001475922pri:TermLifeAndOtherMember2023-03-310001475922srt:ScenarioPreviouslyReportedMember2022-01-012022-03-310001475922pri:TemporaryStockholdersEquityMember2021-01-012021-12-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberpri:CommissionsAndFeesMemberpri:AssetBasedRevenuesMemberpri:InvestmentAndSavingsProductsSegmentRevenuesMember2022-01-012022-03-310001475922us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310001475922pri:AllOtherReinsurersMember2023-03-310001475922srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMemberus-gaap:AccumulatedOtherComprehensiveIncomeMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2022-01-012022-12-310001475922us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FixedMaturitiesMember2022-01-012022-03-310001475922pri:SCORGlobalLifeReinsuranceCompaniesMembersrt:AMBestAPlusRatingMember2022-12-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922us-gaap:AdditionalPaidInCapitalMember2021-12-310001475922us-gaap:ForeignGovernmentDebtSecuritiesMember2023-03-310001475922srt:MaximumMember2023-03-310001475922us-gaap:RetainedEarningsMembersrt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2022-01-012022-12-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberus-gaap:CorporateAndOtherMemberus-gaap:OtherIncomeMember2023-01-012023-03-310001475922srt:AMBestAPlusRatingMemberpri:MunichAmericanReassuranceCompanyMember2022-12-310001475922us-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922pri:SCORGlobalLifeReinsuranceCompaniesMembersrt:AMBestAPlusRatingMember2023-03-310001475922us-gaap:CashAndCashEquivalentsMember2022-01-012022-03-310001475922pri:FixedMaturitySecuritiesMember2023-03-3100014759222022-11-170001475922pri:SeniorHealthSegmentRevenuesMember2023-03-310001475922pri:TemporaryStockholdersEquityMember2022-12-310001475922us-gaap:CashAndCashEquivalentsMember2023-01-012023-03-3100014759222023-03-310001475922us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001475922pri:KoreanReinsuranceCompanyMembersrt:AMBestARatingMember2023-03-310001475922pri:InvestmentAndSavingsProductsSegmentRevenuesMember2022-12-310001475922pri:TermLifeMember2021-12-310001475922us-gaap:CommonStockMember2022-03-310001475922us-gaap:OtherLongTermInvestmentsMember2023-03-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922us-gaap:CorporateDebtSecuritiesMemberus-gaap:ShortTermInvestmentsMember2022-12-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922us-gaap:CorporateAndOtherMember2021-12-310001475922pri:TemporaryStockholdersEquityMember2022-01-012022-12-310001475922us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2022-12-310001475922srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember2022-01-012022-12-310001475922us-gaap:USTreasuryAndGovernmentMember2023-03-310001475922us-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-03-310001475922us-gaap:ShortTermInvestmentsMember2023-03-310001475922us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:ShortTermInvestmentsMember2022-12-310001475922us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922us-gaap:AdditionalPaidInCapitalMember2022-12-310001475922pri:OtherAssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922us-gaap:RetainedEarningsMember2022-01-012022-12-310001475922country:CA2023-03-310001475922country:US2023-01-012023-03-310001475922us-gaap:ShortTermInvestmentsMember2022-12-310001475922us-gaap:CorporateDebtSecuritiesMemberus-gaap:ShortTermInvestmentsMember2023-03-3100014759222022-12-310001475922us-gaap:CorporateAndOtherMember2022-01-012022-03-310001475922us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922us-gaap:RetainedEarningsMember2021-12-310001475922us-gaap:FairValueInputsLevel2Memberpri:FixedMaturitySecuritiesAndShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberus-gaap:OtherIncomeMemberpri:InvestmentAndSavingsProductsSegmentRevenuesMember2023-01-012023-03-310001475922us-gaap:ResidentialMortgageBackedSecuritiesMember2022-12-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberpri:SeniorHealthSegmentRevenuesMemberus-gaap:OtherIncomeMember2022-01-012022-03-310001475922us-gaap:FairValueInputsLevel3Memberpri:FixedMaturitySecuritiesAndShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberpri:TermLifeInsuranceSegmentRevenuesMember2023-01-012023-03-310001475922us-gaap:CommercialMortgageBackedSecuritiesMember2022-12-310001475922pri:RevenuesFromSourcesOtherThanContractsWithCustomersMemberpri:TermLifeInsuranceSegmentRevenuesMember2022-01-012022-03-310001475922pri:TemporaryStockholdersEquityMember2020-12-310001475922pri:OtherAssetBackedSecuritiesMember2022-12-310001475922pri:TemporaryStockholdersEquityMember2022-03-310001475922us-gaap:USTreasuryAndGovernmentMember2022-12-310001475922us-gaap:RetainedEarningsMember2021-01-012021-12-310001475922pri:RevenuesFromSourcesOtherThanContractsWithCustomersMemberpri:TermLifeInsuranceSegmentRevenuesMember2023-01-012023-03-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberpri:SalesBasedRevenuesMemberpri:CommissionsAndFeesMemberpri:InvestmentAndSavingsProductsSegmentRevenuesMember2023-01-012023-03-310001475922country:CA2022-01-012022-03-310001475922us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001475922us-gaap:AccumulatedOtherComprehensiveIncomeMembersrt:ScenarioPreviouslyReportedMember2020-12-310001475922pri:OtherAssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2023-03-310001475922pri:FixedMaturitySecuritiesAndShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2023-03-310001475922us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001475922us-gaap:FairValueInputsLevel2Memberpri:OtherAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922us-gaap:LetterOfCreditMember2023-03-310001475922us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2022-12-310001475922us-gaap:CommonStockMember2021-01-012021-12-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberus-gaap:CorporateAndOtherMember2022-01-012022-03-310001475922us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922us-gaap:FixedMaturitiesMemberus-gaap:HeldtomaturitySecuritiesMember2022-01-012022-03-310001475922us-gaap:FixedMaturitiesMemberus-gaap:USTreasuryAndGovernmentMember2023-03-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberus-gaap:CorporateAndOtherMember2023-01-012023-03-310001475922pri:ToaReinsuranceCompanyMembersrt:AMBestARatingMember2023-03-310001475922srt:AMBestBPlusPlusRatingMemberpri:AmericanHealthAndLifeInsuranceCompanyMember2022-12-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922pri:FixedMaturitySecuritiesAndShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2023-03-310001475922us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922pri:SeniorHealthSegmentRevenuesMember2021-12-310001475922srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMemberus-gaap:AccumulatedOtherComprehensiveIncomeMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001475922srt:AMBestAPlusRatingMemberpri:SwissReLifeHealthAmericaIncNovatedFromPecanReIncMember2023-03-310001475922pri:PolicyLoansAndOtherInvestedAssetsMember2023-01-012023-03-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberus-gaap:OtherIncomeMemberpri:TermLifeInsuranceSegmentRevenuesMember2022-01-012022-03-310001475922us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001475922pri:SeniorHealthSegmentRevenuesMember2022-03-310001475922us-gaap:RetainedEarningsMember2022-12-310001475922us-gaap:FixedIncomeSecuritiesMember2022-12-310001475922us-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberus-gaap:BaseRateMember2023-01-012023-03-310001475922us-gaap:CorporateDebtSecuritiesMember2022-12-310001475922us-gaap:RetainedEarningsMembersrt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001475922us-gaap:EquitySecuritiesMember2022-01-012022-03-310001475922us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001475922pri:RGAReinsuranceMembersrt:AMBestAPlusRatingMember2023-03-310001475922pri:HannoverLifeReassuranceCompanyMembersrt:AMBestAPlusRatingMember2023-03-310001475922us-gaap:CashAndCashEquivalentsMember2022-12-310001475922pri:OtherMember2023-03-310001475922pri:TermLifeMember2023-01-012023-03-310001475922srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember2022-12-310001475922pri:RGAReinsuranceMembersrt:AMBestAPlusRatingMember2022-12-3100014759222021-01-010001475922pri:SurplusNoteMember2023-01-012023-03-310001475922us-gaap:FixedMaturitiesMemberus-gaap:HeldtomaturitySecuritiesMember2023-01-012023-03-310001475922us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922pri:SurplusNoteMember2023-03-310001475922us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:ShortTermInvestmentsMember2023-03-310001475922us-gaap:RetainedEarningsMember2023-01-012023-03-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMember2022-12-310001475922us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2023-03-310001475922us-gaap:FixedIncomeSecuritiesMember2023-03-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberpri:InvestmentAndSavingsProductsSegmentRevenuesMember2023-01-012023-03-310001475922us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001475922us-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001475922country:CA2022-12-310001475922pri:RevenuesFromSourcesOtherThanContractsWithCustomersMemberpri:InvestmentAndSavingsProductsSegmentRevenuesMember2022-01-012022-03-310001475922us-gaap:FairValueMeasurementsRecurringMember2022-03-310001475922pri:DueToFromFundsNettingArrangementMember2023-03-310001475922pri:TermLifeMember2022-01-012022-12-310001475922us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2022-12-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922pri:LLCNoteMember2023-03-310001475922us-gaap:CommonStockMember2023-01-012023-03-310001475922us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922pri:SegregatedFundsCanadaMember2021-12-3100014759222023-03-012023-03-310001475922pri:FixedMaturitySecuritiesAndShortTermInvestmentsMember2023-03-310001475922pri:ExpenseDeferredMember2023-01-012023-03-310001475922us-gaap:RetainedEarningsMember2020-12-310001475922us-gaap:RetainedEarningsMembersrt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2020-12-310001475922us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FixedMaturitiesMember2023-03-310001475922us-gaap:CorporateAndOtherMemberpri:RevenuesFromSourcesOtherThanContractsWithCustomersMember2022-01-012022-03-310001475922us-gaap:TermLifeInsuranceMember2022-12-310001475922us-gaap:RevolvingCreditFacilityMember2023-01-012023-03-310001475922us-gaap:AdditionalPaidInCapitalMember2020-12-310001475922us-gaap:OtherLongTermInvestmentsMember2022-12-310001475922us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-310001475922us-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310001475922us-gaap:FairValueMeasurementsRecurringMember2021-12-310001475922pri:ExpenseDeferredMember2022-01-012022-03-310001475922us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2023-03-310001475922us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001475922us-gaap:FixedMaturitiesMember2022-12-310001475922us-gaap:CommonStockMember2023-03-310001475922pri:OtherAssetBackedSecuritiesMember2023-03-310001475922us-gaap:ShortTermInvestmentsMember2022-12-310001475922us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001475922pri:DepositAssetUnderlying10InsuranceAgreementMember2022-01-012022-03-310001475922pri:FixedMaturitySecuritiesAndShortTermInvestmentsMember2022-12-310001475922us-gaap:RetainedEarningsMember2022-01-012022-03-310001475922us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922pri:TermLifeInsuranceSegmentRevenuesMember2023-01-012023-03-310001475922pri:SeniorHealthSegmentRevenuesMember2022-12-310001475922us-gaap:ShortTermInvestmentsMemberus-gaap:USTreasuryAndGovernmentMember2022-12-310001475922us-gaap:PerformanceSharesMember2023-03-310001475922pri:AccountBasedRevenuesMemberpri:SegmentRevenuesFromContractsWithCustomersMemberpri:CommissionsAndFeesMemberpri:InvestmentAndSavingsProductsSegmentRevenuesMember2023-01-012023-03-310001475922pri:RevenuesFromSourcesOtherThanContractsWithCustomersMemberpri:InvestmentAndSavingsProductsSegmentRevenuesMember2023-01-012023-03-310001475922pri:SegregatedFundsCanadaMember2023-03-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMember2023-03-310001475922us-gaap:FairValueMeasurementsRecurringMember2023-01-012023-03-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-3100014759222022-03-310001475922us-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310001475922us-gaap:ShortTermInvestmentsMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2022-12-310001475922us-gaap:RevolvingCreditFacilityMember2023-03-310001475922pri:ExternalCreditRatingNotRatedMemberpri:MunichReOfMaltaMember2022-12-310001475922us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922pri:ToaReinsuranceCompanyMembersrt:AMBestARatingMember2022-12-310001475922us-gaap:RetainedEarningsMember2023-03-310001475922us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberpri:SalesBasedRevenuesMemberpri:CommissionsAndFeesMemberpri:InvestmentAndSavingsProductsSegmentRevenuesMember2022-01-012022-03-3100014759222021-12-310001475922us-gaap:OtherInsuranceProductLineMember2023-03-310001475922us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922us-gaap:ForeignGovernmentDebtSecuritiesMember2022-12-310001475922srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember2022-01-012022-03-310001475922pri:TermLifeMember2023-03-310001475922pri:EtelequoteBermudaMember2022-07-012022-07-010001475922pri:SegregatedFundsCanadaMember2022-01-012022-12-310001475922us-gaap:FixedMaturitiesMemberus-gaap:USTreasuryAndGovernmentMember2022-12-310001475922pri:PolicyLoansAndOtherInvestedAssetsMember2022-01-012022-03-310001475922us-gaap:USStatesAndPoliticalSubdivisionsMember2022-12-310001475922us-gaap:FairValueMeasurementsRecurringMember2022-01-012022-03-310001475922us-gaap:RetainedEarningsMembersrt:ScenarioPreviouslyReportedMember2020-12-310001475922us-gaap:EquitySecuritiesMember2022-12-310001475922us-gaap:FixedMaturitiesMember2023-03-310001475922us-gaap:TermLifeInsuranceMember2023-03-310001475922us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001475922pri:SeniorHealthSegmentRevenuesMember2023-01-012023-03-310001475922us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FixedMaturitiesMember2023-01-012023-03-310001475922pri:FixedMaturitySecuritiesMember2022-12-310001475922us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001475922pri:SegregatedFundsCanadaMember2022-12-310001475922us-gaap:CorporateDebtSecuritiesMember2023-03-310001475922us-gaap:RevolvingCreditFacilityMembersrt:MinimumMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-03-310001475922srt:AMBestBPlusPlusRatingMemberpri:AmericanHealthAndLifeInsuranceCompanyMember2023-03-310001475922pri:SegmentRevenuesFromContractsWithCustomersMemberus-gaap:CorporateAndOtherMemberpri:CommissionsAndFeesMember2023-01-012023-03-3100014759222023-04-300001475922pri:TermLifeMember2022-12-310001475922us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001475922us-gaap:CommonStockMember2021-12-310001475922us-gaap:CorporateAndOtherMember2023-01-012023-03-310001475922pri:TermLifeInsuranceSegmentRevenuesMember2023-03-310001475922us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2023-03-310001475922us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2023-03-310001475922srt:AMBestAPlusRatingMemberpri:MunichAmericanReassuranceCompanyMember2023-03-310001475922us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001475922us-gaap:CorporateAndOtherMember2022-03-310001475922pri:AccountBasedRevenuesMemberpri:SegmentRevenuesFromContractsWithCustomersMemberpri:CommissionsAndFeesMemberpri:InvestmentAndSavingsProductsSegmentRevenuesMember2022-01-012022-03-31pri:Segmentxbrli:purexbrli:sharesiso4217:USDxbrli:sharesiso4217:USD

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-34680

img185880966_0.jpg 

Primerica, Inc.

(Exact name of registrant as specified in its charter)

Delaware

27-1204330

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

1 Primerica Parkway

Duluth, Georgia

30099

(Address of principal executive offices)

(ZIP Code)

(770) 381-1000

(Registrant’s telephone number, including area code)

Not applicable.

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock

 

PRI

 

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer



Accelerated filer

Non-accelerated filer



Smaller reporting company

Emerging growth company



 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of April 30, 2023, the registrant had 36,226,210 shares of common stock, $0.01 par value per share, outstanding.

 

 


 

 

 


 

TABLE OF CONTENTS

 

 

 

 

 

 

Page

PART I – FINANCIAL INFORMATION

 

2

Item 1. Financial Statements (unaudited).

 

2

Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022

 

2

Condensed Consolidated Statements of Income for the three months ended March 31, 2023 and 2022

 

3

Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2023 and 2022

 

4

Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2023 and 2022

 

5

Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022

 

6

Notes to Condensed Consolidated Financial Statements

 

7

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

33

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

52

Item 4. Controls and Procedures.

 

52

 

PART II – OTHER INFORMATION

 

52

Item 1. Legal Proceedings.

 

52

Item 1A. Risk Factors.

 

52

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

53

Item 5. Other Information

 

53

Item 6. Exhibits.

 

53

Signatures

 

55

 

 

i


 

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

PRIMERICA, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets – Unaudited

 

 

March 31, 2023

 

 

December 31, 2022

 

 

 

(In thousands)

 

Assets:

 

 

 

 

 

 

Investments:

 

 

 

 

 

 

Fixed-maturity securities available-for-sale, at fair value (amortized cost: $2,822,996 in 2023
   and $
2,801,415 in 2022)

 

$

2,558,626

 

 

$

2,495,456

 

Fixed-maturity security held-to-maturity, at amortized cost (fair value: $1,388,411 in 2023 and
   $
1,340,265 in 2022)

 

 

1,460,000

 

 

 

1,444,920

 

Short-term investments available-for-sale, at fair value (amortized cost: $70,185 in 2023
   and $
69,393 in 2022)

 

 

70,187

 

 

 

69,406

 

Equity securities, at fair value (historical cost: $29,475 in 2023 and $29,430 in 2022)

 

 

33,984

 

 

 

35,404

 

Trading securities, at fair value (cost: $19,033 in 2023 and $4,229 in 2022)

 

 

18,497

 

 

 

3,698

 

Policy loans and other invested assets

 

 

50,003

 

 

 

48,713

 

Total investments

 

 

4,191,297

 

 

 

4,097,597

 

Cash and cash equivalents

 

 

515,090

 

 

 

489,240

 

Accrued investment income

 

 

22,153

 

 

 

20,885

 

Reinsurance recoverables

 

 

3,179,074

 

 

 

3,176,397

 

Deferred policy acquisition costs, net

 

 

3,256,845

 

 

 

3,194,029

 

Renewal commissions receivable

 

 

194,409

 

 

 

200,043

 

Agent balances, due premiums and other receivables

 

 

259,759

 

 

 

254,276

 

Goodwill

 

 

127,707

 

 

 

127,707

 

Intangible assets, net (accumulated amortization: $18,375 in 2023 and $15,750 in 2022)

 

 

182,900

 

 

 

185,525

 

Income taxes

 

 

106,310

 

 

 

97,972

 

Operating lease right-of-use assets

 

 

38,575

 

 

 

40,500

 

Other assets

 

 

391,605

 

 

 

428,259

 

Separate account assets

 

 

2,329,968

 

 

 

2,305,717

 

Total assets

 

$

14,795,692

 

 

$

14,618,147

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity:

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

Future policy benefits

 

$

6,561,624

 

 

$

6,297,906

 

Unearned and advance premiums

 

 

16,703

 

 

 

15,422

 

Policy claims and other benefits payable

 

 

498,483

 

 

 

538,250

 

Other policyholders’ funds

 

 

481,561

 

 

 

483,769

 

Note payable

 

 

593,106

 

 

 

592,905

 

Surplus note

 

 

1,459,565

 

 

 

1,444,469

 

Income taxes

 

 

199,394

 

 

 

202,462

 

Operating lease liabilities

 

 

43,955

 

 

 

45,995

 

Other liabilities

 

 

615,780

 

 

 

580,780

 

Payable under securities lending

 

 

74,452

 

 

 

100,938

 

Separate account liabilities

 

 

2,329,968

 

 

 

2,305,717

 

Commitments and contingent liabilities (see Commitments and Contingent Liabilities note)

 

 

 

 

 

 

Total liabilities

 

 

12,874,591

 

 

 

12,608,613

 

 

 

 

 

 

 

 

Temporary Stockholders’ Equity

 

 

 

 

 

 

Redeemable noncontrolling interests in consolidated entities

 

 

-

 

 

 

-

 

Permanent Stockholders’ Equity

 

 

 

 

 

 

Equity attributable to Primerica, Inc.:

 

 

 

 

 

 

Common stock ($0.01 par value; authorized 500,000 shares in 2023 and 2022; issued and
   outstanding
36,407 shares in 2023 and 36,824 shares in 2022)

 

 

364

 

 

 

368

 

Paid-in capital

 

 

-

 

 

 

-

 

Retained earnings

 

 

2,151,771

 

 

 

2,130,935

 

Accumulated other comprehensive income (loss), net of income tax:

 

 

 

 

 

 

Effect of change in discount rate assumptions on the liability for future policy benefits

 

 

(11,679

)

 

 

131,295

 

Unrealized foreign currency translation gains (losses)

 

 

(11,198

)

 

 

(12,196

)

Net unrealized investment gains (losses) on available-for-sale securities

 

 

(208,157

)

 

 

(240,868

)

Total permanent stockholders’ equity

 

 

1,921,101

 

 

 

2,009,534

 

Total liabilities and temporary and permanent stockholders’ equity

 

$

14,795,692

 

 

$

14,618,147

 

 

 

 

 

 

 

 

Prior year amounts related to long-duration insurance contracts have been adjusted for the adoption of accounting guidance on January 1, 2023.

See accompanying notes to condensed consolidated financial statements.

 

2


 

PRIMERICA, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Income – Unaudited

 

 

Three months ended March 31,

 

 

 

 

2023

 

 

2022

 

 

 

 

(In thousands, except per-share amounts)

Revenues:

 

 

 

 

 

 

 

Direct premiums

 

$

817,872

 

 

$

798,666

 

 

Ceded premiums

 

 

(405,347

)

 

 

(399,885

)

 

Net premiums

 

 

412,525

 

 

 

398,781

 

 

Commissions and fees

 

 

231,547

 

 

 

251,800

 

 

Investment income net of investment expenses

 

 

47,500

 

 

 

34,420

 

 

Interest expense on surplus note

 

 

(16,435

)

 

 

(15,515

)

 

Net investment income

 

 

31,065

 

 

 

18,905

 

 

Realized investment gains (losses)

 

 

(985

)

 

 

577

 

 

Other investment gains (losses)

 

 

(3,623

)

 

 

174

 

 

Investment gains (losses)

 

 

(4,608

)

 

 

751

 

 

Other, net

 

 

19,507

 

 

 

20,989

 

 

Total revenues

 

 

690,036

 

 

 

691,226

 

 

 

 

 

 

 

 

 

 

Benefits and expenses:

 

 

 

 

 

 

 

Benefits and claims

 

 

168,702

 

 

 

168,288

 

 

Future policy benefits remeasurement (gain) loss

 

 

(508

)

 

 

(1,272

)

 

Amortization of deferred policy acquisition costs

 

 

67,358

 

 

 

63,223

 

 

Sales commissions

 

 

110,874

 

 

 

133,924

 

 

Insurance expenses

 

 

61,125

 

 

 

59,509

 

 

Insurance commissions

 

 

8,138

 

 

 

7,721

 

 

Contract acquisition costs

 

 

14,984

 

 

 

20,649

 

 

Interest expense

 

 

6,690

 

 

 

6,853

 

 

Other operating expenses

 

 

89,536

 

 

 

86,435

 

 

Total benefits and expenses

 

 

526,899

 

 

 

545,330

 

 

Income before income taxes

 

 

163,137

 

 

 

145,896

 

 

Income taxes

 

 

38,031

 

 

 

33,512

 

 

Net income

 

 

125,106

 

 

 

112,384

 

 

Net income (loss) attributable to noncontrolling interests

 

 

-

 

 

 

(2,655

)

 

Net income attributable to Primerica, Inc.

 

$

125,106

 

 

$

115,039

 

 

 

 

 

 

 

 

 

 

Earnings per share attributable to common stockholders:

 

 

 

 

 

 

 

Basic earnings per share

 

$

3.39

 

 

$

2.92

 

 

Diluted earnings per share

 

$

3.38

 

 

$

2.91

 

 

 

 

 

 

 

 

 

 

Weighted-average shares used in computing earnings
   per share:

 

 

 

 

 

 

 

Basic

 

 

36,710

 

 

 

39,221

 

 

Diluted

 

 

36,804

 

 

 

39,332

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Prior year amounts related to long-duration insurance contracts have been adjusted for the adoption of accounting guidance on January 1, 2023.

See accompanying notes to condensed consolidated financial statements.

 

 

3


 

 

PRIMERICA, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income (Loss) – Unaudited

 

 

Three months ended March 31,

 

 

 

2023

 

 

2022

 

 

(In thousands)

 

Net income

 

$

125,106

 

 

$

112,384

 

Other comprehensive income (loss) before income taxes:

 

 

 

 

 

 

Unrealized investment gains (losses) on available-for-sale securities:

 

 

 

 

 

 

Change in unrealized holding gains (losses) on available-for-sale securities

 

 

38,549

 

 

 

(164,937

)

Reclassification adjustment for investment (gains) losses included in net income

 

 

3,137

 

 

 

(658

)

Effect of change in discount rate assumptions on the liability for future policy benefits

 

 

(182,045

)

 

 

821,904

 

Foreign currency translation adjustments:

 

 

 

 

 

 

Change in unrealized foreign currency translation gains (losses)

 

 

998

 

 

 

3,289

 

Total other comprehensive income (loss) before income taxes

 

 

(139,361

)

 

 

659,598

 

Income tax expense (benefit) related to items of other comprehensive income (loss)

 

 

(30,096

)

 

 

140,384

 

Other comprehensive income (loss), net of income taxes

 

 

(109,265

)

 

 

519,214

 

Total comprehensive income (loss)

 

 

15,841

 

 

 

631,598

 

Net income (loss) attributable to noncontrolling interests

 

 

-

 

 

 

(2,655

)

Comprehensive income (loss) attributable to Primerica, Inc.

 

$

15,841

 

 

$

634,253

 

 

 

 

 

 

 

 

Prior year amounts related to long-duration insurance contracts have been adjusted for the adoption of accounting guidance on January 1, 2023.

See accompanying notes to condensed consolidated financial statements.

 

4


 

PRIMERICA, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Stockholders’ Equity– Unaudited

 

 

Three months ended March 31,

 

 

 

2023

 

 

2022

 

 

 

(In thousands)

 

Equity attributable to Primerica, Inc./Permanent stockholders’ equity

 

 

 

 

 

 

Common stock:

 

 

 

 

 

 

Balance, beginning of period

 

$

368

 

 

$

394

 

Repurchases of common stock

 

 

(6

)

 

 

(7

)

Net issuance of common stock

 

 

2

 

 

 

1

 

Balance, end of period

 

 

364

 

 

 

388

 

 

 

 

 

 

 

 

Paid-in capital:

 

 

 

 

 

 

Balance, beginning of period

 

 

-

 

 

 

5,224

 

Share-based compensation

 

 

16,622

 

 

 

14,820

 

Net issuance of common stock

 

 

(2

)

 

 

(1

)

Repurchases of common stock

 

 

(16,620

)

 

 

(20,043

)

Balance, end of period

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

Retained earnings:

 

 

 

 

 

 

Adjusted balance, beginning of period

 

 

2,130,935

 

 

 

2,074,111

 

Net income attributable to Primerica, Inc.

 

 

125,106

 

 

 

115,039

 

Dividends

 

 

(23,910

)

 

 

(21,645

)

Repurchases of common stock

 

 

(80,360

)

 

 

(83,813

)

Balance, end of period

 

 

2,151,771

 

 

 

2,083,692

 

 

 

 

 

 

 

 

Accumulated other comprehensive income (loss), net of income tax:

 

 

 

 

 

 

Adjusted balance, beginning of period

 

 

(121,769

)

 

 

(1,168,399

)

Effect of change in discount rate assumptions on the liability for future policy benefits

 

 

(142,974

)

 

 

646,141

 

Change in foreign currency translation adjustment

 

 

998

 

 

 

3,289

 

Change in net unrealized investment gains (losses) during the period

 

 

32,711

 

 

 

(130,216

)

Balance, end of period

 

 

(231,034

)

 

 

(649,185

)

 

 

 

 

 

 

 

Total permanent stockholders’ equity

 

$

1,921,101

 

 

$

1,434,895

 

 

 

 

 

 

 

 

Redeemable noncontrolling interests in consolidated entities/Temporary stockholders’ equity

 

 

 

 

 

 

Balance, beginning of period

 

$

-

 

 

$

7,271

 

Net income (loss) attributable to noncontrolling interests

 

 

-

 

 

 

(2,655

)

Balance, end of period

 

$

-

 

 

$

4,616

 

 

 

 

 

 

 

 

Dividends declared per share

 

$

0.65

 

 

$

0.55

 

Prior year amounts related to long-duration insurance contracts have been adjusted for the adoption of accounting guidance on January 1, 2023.

See accompanying notes to condensed consolidated financial statements.

 

5


 

PRIMERICA, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows – Unaudited

 

 

Three months ended March 31,

 

 

 

2023

 

 

2022

 

 

 

(In thousands)

 

Cash flows from operating activities:

 

 

 

 

 

 

Net income

 

$

125,106

 

 

$

112,384

 

Adjustments to reconcile net income to cash provided by (used in) operating activities:

 

 

 

 

 

 

Change in future policy benefits and other policy liabilities

 

 

(9,799

)

 

 

(161,385

)

Deferral of policy acquisition costs

 

 

(126,640

)

 

 

(130,881

)

Amortization of deferred policy acquisition costs

 

 

67,358

 

 

 

63,223

 

Change in income taxes

 

 

18,713

 

 

 

14,171

 

Investment (gains) losses

 

 

4,608

 

 

 

(751

)

Accretion and amortization of investments

 

 

(309

)

 

 

1,356

 

Depreciation and amortization

 

 

8,547

 

 

 

8,688

 

Change in reinsurance recoverables

 

 

47,766

 

 

 

248,511

 

Change in agent balances, due premiums and other receivables

 

 

(5,486

)

 

 

2,245

 

Change in renewal commissions receivable

 

 

5,634

 

 

 

18,576

 

Trading securities sold, matured, or called (acquired), net

 

 

(14,808

)

 

 

11,273

 

Share-based compensation

 

 

12,129

 

 

 

12,437

 

Change in other operating assets and liabilities, net

 

 

43,127

 

 

 

14,452

 

Net cash provided by (used in) operating activities

 

 

175,946

 

 

 

214,299

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

Available-for-sale investments sold, matured or called:

 

 

 

 

 

 

Fixed-maturity securities — sold

 

 

5,179

 

 

 

1,227

 

Fixed-maturity securities — matured or called

 

 

80,251

 

 

 

96,336

 

Short-term investments — matured or called

 

 

-

 

 

 

41,550

 

Equity securities — sold

 

 

5

 

 

 

-

 

Equity securities — matured or called

 

 

-